Modem biotechnology-the application of in vitro techniques such as rec
ombinant DNA, monoclonal antibodies, and tissue culture-is a relativel
y small endeavor in Mexico, at least by U.S. standards, but it is nota
ble among newly industrialized countries. Unfortunately, despite the p
otential importance of biotechnology to Mexican industry in the fields
of agriculture, food processing, environmental management, and pharma
ceuticals, the nation has been unable to harness its scientific effort
in the service of economic development. This article presents finding
s from a series of face-to-face interviews with over two dozen of Mexi
co's leaders in science, industry, and government regarding biotechnol
ogy. The study revealed the pattern of development of biotechnology in
Mexico, the reasons behind the longstanding chasm behind science and
industry, some hard-won lessons in attempts at commercializing the tec
hnology, and the seeds of change that have been accelerated by recent
economic and political turmoil. It appears researchers and business pe
ople are becoming increasingly aware that the economic strides fostere
d by technological innovation require not only a scientific base, but
its transfer to the marketplace. Strengthening the infrastructure that
catalyzes the linkage remains Mexico's greatest challenge in reaping
the benefits of biotechnology. (C) 1998 Elsevier Science Ltd. All righ
ts reserved.